You are being forwarded to your requested URL of https://www.fdalawblog.com/2023/06/articles/fda/fda-issues-first-untitled-letter-of-the-year-to-xeris-pharmaceuticals/?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=